Sign in to view content

Preoperative Intravitreal Bevacizumab for TRD Secondary to PDR: A Prospective Randomized Clinical Trial of the PACORES Group

J. Fernando Arevalo, MD, PhD, FACS, FASRS

Video
Published 2018

Related

Controlling Uveitic Recurrences: Results From a Phase 3 Study of 0.18 mg Fluocinolone Acetonide Insert (FAi) in Noninfectious Posterior Uveitis
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2018
Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2018
ASRS Presidents' Retina Young Investigators Award, Advancing Insights Into Diabetic Eye Disease, Rishi P. Singh, MD
Rishi P. Singh, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

2018 Annual Meeting

See more